Archive · Business Recorder
Pakistani diabetes medicines match multinational brands: experts
LAHORE: In Pakistan, where millions of families struggle to make both ends meet and cannot afford costly treatment, a local study found that Pakistani biosimilar medicines deliver diabetes control and weight loss comparable to their multinational counterparts. The findings were presented at the concluding day of PESCON 2026, the Pakistan Endocrine Society’s 24th annual conference. Medical experts said Pakistani alternatives cost about one quarter of multinational brands, potentially making treatment accessible to poorer patients. They stressed that affordability was essential for people requir...
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Business Recorder →